Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 399.9 | 174.5 | 91.5 | 86.7 | 77.2 | 55.0 |
| Revenue growth | 129.1% | 90.7% | 5.6% | 12.3% | 40.4% | |
| Cost of goods sold | 78.2 | 48.3 | 42.2 | 37.5 | 33.0 | 20.2 |
| Gross profit | 321.7 | 126.3 | 49.4 | 49.2 | 44.2 | 34.8 |
| Gross margin | 80.4% | 72.3% | 53.9% | 56.7% | 57.3% | 63.3% |
| Selling, general and administrative | 32.9 | | | | | 6.5 |
| Research and development | | 7.1 | 5.4 | 4.6 | 3.1 | |
| General and administrative | 9.9 | 16.6 | 9.0 | 8.1 | 9.4 | 2.6 |
| EBIT | 288.8 | 80.2 | 28.4 | 45.0 | 30.4 | 28.3 |
| EBIT margin | 72.2% | 45.9% | 31.0% | 51.9% | 39.4% | 51.4% |
| Pre-tax income | -931.2 | 85.4 | 31.2 | 34.7 | 30.4 | 14.4 |
| Income taxes | 6.7 | 6.9 | 5.2 | 9.8 | 8.1 | 6.8 |
| Tax rate | | 8.1% | 16.5% | 28.3% | 26.5% | 47.0% |
| Net income | -948.7 | 75.5 | 26.0 | 24.8 | 22.3 | 7.6 |
| Net margin | -237.2% | 43.3% | 28.4% | 28.7% | 28.9% | 13.9% |
| |
| Diluted EPS | ($30.07) | $2.91 | $1.36 | $1.35 | $1.31 | $0.79 |
| Shares outstanding (diluted) | 31.5 | 25.9 | 19.2 | 18.4 | 17.0 | 9.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|